Widget

Add BioCurex widget to your own site or blog

Narrow [210x500] Wide [800x150] Copy and Paste the following code:

View Narrow Widget

Email Updates

AGORACOM News Flash

AGORACOM CONFERENCE UPDATE

12 More Companies Added To Schedule For Dec 3 & 4. (See Schedule)
Keynote Speakers Include Peter Grandich, Eric Coffin (See Speakers)
Workshop Presentations Added To Thursday Schedule
Investors from over 45 Countries Have Visited
Conference Begins 2 Weeks From Today!

Looking forward to seeing all of you there gang. Registration is free for investors. AGORACOM Members register with just one click. Non-members takes less than 60 seconds. Register here (see form on right hand side)

Message: Is selling the company an option?

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

newbie21

This user has been banned for violating Agoracom's Six Rules of Use

Is selling the company an option?

posted on Nov 25, 08 05:24AM

Dr. Moro. In the latest filing, the current cash position is $90,000 which is not enough to continue current operations. If you cannot obtain more funding to pay the loan, will the lack of money cause the company be sold? Does the hedge fund have any lien on the latest patents or any additional patent grants? Does the hedge fund have any lien on BioCurex China?

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »